Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Microsoft stock has weakened ahead of the company’s fiscal first-quarter report next Wednesday as investors are skittish on AI names. The post Microsoft Earnings Report To Focus On AI Momentum, Capex appeared first on Investor’s Business Daily.
The S&P 500 and Nasdaq tumbled below 50-day lines as Meta led an AI stock rout. But the Warren Buffett market is thriving. The post Dow Jones Futures: Moderna Crashes, Meta Fuels AI Meltdown, But Warren Buffett Market Thriving appeared…
Chipmaker MaxLinear beat expectations for the third quarter and with its guidance for the fourth quarter. The post Chipmaker MaxLinear Delivers Beat-And-Raise Report appeared first on Investor’s Business Daily.
Western Digital stock climbed late Thursday after the hard-disk drive maker reported fiscal first-quarter results. The post AI Stock Western Digital Gains After Earnings Beat. Here Are Numbers To Know. appeared first on Investor’s Business Daily.
Meta saw an initial rally after reporting earnings, before a sharp reversal. It’s all about AI spending. The post Meta, AI Stocks Tumble As AI Spending Fears Reignite appeared first on Investor’s Business Daily.
Chip stocks fell Thursday despite solid quarterly earnings reports from Texas Instruments and Lam Research. The post Chip Stocks Tumble Despite Solid Earnings Reports appeared first on Investor’s Business Daily.
Quest Diagnostics did “good enough” against an “increasingly high bar,” an analyst said Thursday. But Quest stock fell moderately. The post Why Quest’s ‘Good Enough’ Third Quarter Wasn’t Actually Enough appeared first on Investor’s Business Daily.
Tesla CEO Elon Musk told investors to be patient when it came to progress on robotaxi expansion and Optimus development. The post Analysts Hike Tesla Price Targets; SpaceX Merger, AI ‘In Full Control’ appeared first on Investor’s Business Daily.
Roche stock was unmoved early Thursday after the drugmaker matched sales expectations despite light pharma sales. The post Roche, In A Buy Zone, Matches Revenue Forecasts Despite Light Pharma Sales appeared first on Investor’s Business Daily.
Argenx stock fell early Thursday despite beating sales expectations on a surprise testing requirement for its drug, Vyvgart. The post Argenx Slumps On Mixed Third Quarter, Surprise Vyvgart Testing Plans appeared first on Investor’s Business Daily.